Ventricular Pacing Site Selection (V-PASS)
A Randomized, Prospective Multicenter Pilot Study to Determine the Influence of the Ventricular Pacing Site on the Incidence of Atrial Fibrillation and Heart Failure in Patients With Indication for Permanent Pacemaker Stimulation Therapy.
Sponsor: Medtronic BRC
This PHASE4 trial investigates Atrioventricular Block and is currently ongoing. Medtronic BRC leads this study, which shows 5 recorded versions since 2026 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic BRC
- Vitatron GmbH
For direct contact, visit the study record on ClinicalTrials.gov .